1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Ophthalmology Surgical Devices Market
4. Market Overview
    4.1. Introduction
        4.1.1. Product Definition
        4.1.2. Industry Evolution/Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Ophthalmology Surgical Devices Market Analysis and Forecast, 2017–2031
5. Key Insights
    5.1. Pipeline Analysis
    5.2. Key Product/Brand Analysis
    5.3. Key Mergers & Acquisitions
    5.4. COVID-19 Pandemic Impact on Industry
6. Global Ophthalmology Surgical Devices Market Analysis and Forecast, by Product
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Product, 2017–2031
        6.3.1. Cataract Surgery Devices
            6.3.1.1. Intraocular Lenses (IOLs)
            6.3.1.2. Ophthalmic Viscoelastic Devices
            6.3.1.3. Others
        6.3.2. Glaucoma Surgery Devices
        6.3.3. Vitreoretinal Surgery Devices
        6.3.4. Refractive Surgery Devices
    6.4. Market Attractiveness Analysis, by Product
7. Global Ophthalmology Surgical Devices Market Analysis and Forecast, by End-user
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by End-user, 2017–2031
        7.3.1. Hospitals
        7.3.2. Ambulatory Surgical Centers
        7.3.3. Ophthalmic Clinics
    7.4. Market Attractiveness Analysis, by End-user
8. Global Ophthalmology Surgical Devices Market Analysis and Forecast, by Region
    8.1. Key Findings
    8.2. Market Value Forecast, by Region, 2017–2031
        8.2.1. North America
        8.2.2. Europe
        8.2.3. Asia Pacific
        8.2.4. Latin America
        8.2.5. Middle East & Africa
    8.3. Market Attractiveness Analysis, by Region
9. North America Ophthalmology Surgical Devices Market Analysis and Forecast
    9.1. Introduction
    9.2. Key Findings
    9.3. Market Value Forecast, by Product, 2017–2031
        9.3.1. Cataract Surgery Devices
            9.3.1.1. Intraocular Lenses (IOLs)
            9.3.1.2. Ophthalmic Viscoelastic Devices
            9.3.1.3. Others
        9.3.2. Glaucoma Surgery Devices
        9.3.3. Vitreoretinal Surgery Devices
        9.3.4. Refractive Surgery Devices
    9.4. Market Value Forecast, by End-user, 2017–2031
        9.4.1. Hospitals
        9.4.2. Ambulatory Surgical Centers
        9.4.3. Ophthalmic Clinics
    9.5. Market Value Forecast, by Country, 2017–2031
        9.5.1. U.S.
        9.5.2. Canada
    9.6. Market Attractiveness Analysis
        9.6.1. By Product
        9.6.2. By End-user
        9.6.3. By Country
10. Europe Ophthalmology Surgical Devices Market Analysis and Forecast
    10.1. Introduction
    10.2. Key Findings
    10.3. Market Value Forecast, by Product, 2017–2031
        10.3.1. Cataract Surgery Devices
            10.3.1.1. Intraocular Lenses (IOLs)
            10.3.1.2. Ophthalmic Viscoelastic Devices
            10.3.1.3. Others
        10.3.2. Glaucoma Surgery Devices
        10.3.3. Vitreoretinal Surgery Devices
        10.3.4. Refractive Surgery Devices
    10.4. Market Value Forecast, by End-user, 2017–2031
        10.4.1. Hospitals
        10.4.2. Ambulatory Surgical Centers
        10.4.3. Ophthalmic Clinics
    10.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        10.5.1. Germany
        10.5.2. U.K.
        10.5.3. France
        10.5.4. Italy
        10.5.5. Spain
        10.5.6. Rest of Europe
    10.6. Market Attractiveness Analysis
        10.6.1. By Product
        10.6.2. By End-user
        10.6.3. By Country/Sub-region
11. Asia Pacific Ophthalmology Surgical Devices Market Analysis and Forecast
    11.1. Introduction
    11.2. Key Findings
    11.3. Market Value Forecast, by Product, 2017–2031
        11.3.1. Cataract Surgery Devices
            11.3.1.1. Intraocular Lenses (IOLs)
            11.3.1.2. Ophthalmic Viscoelastic Devices
            11.3.1.3. Others
        11.3.2. Glaucoma Surgery Devices
        11.3.3. Vitreoretinal Surgery Devices
        11.3.4. Refractive Surgery Devices
    11.4. Market Value Forecast, by End-user, 2017–2031
        11.4.1. Hospitals
        11.4.2. Ambulatory Surgical Centers
        11.4.3. Ophthalmic Clinics
    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        11.5.1. China
        11.5.2. Japan
        11.5.3. India
        11.5.4. Australia & New Zealand
        11.5.5. Rest of Asia Pacific
    11.6. Market Attractiveness Analysis
        11.6.1. By Product
        11.6.2. By End-user
        11.6.3. By Country/Sub-region
12. Latin America Ophthalmology Surgical Devices Market Analysis and Forecast
    12.1. Introduction
    12.2. Key Findings
    12.3. Market Value Forecast, by Product, 2017–2031
        12.3.1. Cataract Surgery Devices
            12.3.1.1. Intraocular Lenses (IOLs)
            12.3.1.2. Ophthalmic Viscoelastic Devices
            12.3.1.3. Others
        12.3.2. Glaucoma Surgery Devices
        12.3.3. Vitreoretinal Surgery Devices
        12.3.4. Refractive Surgery Devices
    12.4. Market Value Forecast, by End-user, 2017–2031
        12.4.1. Hospitals
        12.4.2. Ambulatory Surgical Centers
        12.4.3. Ophthalmic Clinics
    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.5.1. Brazil
        12.5.2. Mexico
        12.5.3. Rest of Latin America
    12.6. Market Attractiveness Analysis
        12.6.1. By Product
        12.6.2. By End-user
        12.6.3. By Country/Sub-region
13. Middle East & Africa Ophthalmology Surgical Devices Market Analysis and Forecast
    13.1. Introduction
    13.2. Key Findings
    13.3. Market Value Forecast, by Product, 2017–2031
        13.3.1. Cataract Surgery Devices
            13.3.1.1. Intraocular Lenses (IOLs)
            13.3.1.2. Ophthalmic Viscoelastic Devices
            13.3.1.3. Others
        13.3.2. Glaucoma Surgery Devices
        13.3.3. Vitreoretinal Surgery Devices
        13.3.4. Refractive Surgery Devices
    13.4. Market Value Forecast, by End-user, 2017–2031
        13.4.1. Hospitals
        13.4.2. Ambulatory Surgical Centers
        13.4.3. Ophthalmic Clinics
    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.5.1. GCC Countries
        13.5.2. South Africa
        13.5.3. Rest of Middle East & Africa
    13.6. Market Attractiveness Analysis
        13.6.1. By Product
        13.6.2. By End-user
        13.6.3. By Country/Sub-region
14. Competition Landscape
    14.1. Market Player – Competitive Matrix (by Tier and Size of Companies)
    14.2. Market Share Analysis, by Company (2022)
    14.3. Company Profiles
        14.3.1. Alcon
            14.3.1.1. Company Overview
            14.3.1.2. Product Portfolio
            14.3.1.3. SWOT Analysis
            14.3.1.4. Financial Overview
            14.3.1.5. Strategic Overview
        14.3.2. Bausch & Lomb, Inc.
            14.3.2.1. Company Overview
            14.3.2.2. Product Portfolio
            14.3.2.3. SWOT Analysis
            14.3.2.4. Financial Overview
            14.3.2.5. Strategic Overview
        14.3.3. Carl Zeiss Meditec AG
            14.3.3.1. Company Overview
            14.3.3.2. Product Portfolio
            14.3.3.3. SWOT Analysis
            14.3.3.4. Financial Overview
            14.3.3.5. Strategic Overview
        14.3.4. Glaukos Corporation
            14.3.4.1. Company Overview
            14.3.4.2. Product Portfolio
            14.3.4.3. SWOT Analysis
            14.3.4.4. Financial Overview
            14.3.4.5. Strategic Overview
        14.3.5. HOYA Corporation
            14.3.5.1. Company Overview
            14.3.5.2. Product Portfolio
            14.3.5.3. SWOT Analysis
            14.3.5.4. Financial Overview
            14.3.5.5. Strategic Overview
        14.3.6. IRIDEX Corporation
            14.3.6.1. Company Overview
            14.3.6.2. Product Portfolio
            14.3.6.3. SWOT Analysis
            14.3.6.4. Financial Overview
            14.3.6.5. Strategic Overview
        14.3.7. Johnson & Johnson Vision Care, Inc.
            14.3.7.1. Company Overview
            14.3.7.2. Product Portfolio
            14.3.7.3. SWOT Analysis
            14.3.7.4. Financial Overview
            14.3.7.5. Strategic Overview
        14.3.8. Lumenis Ltd.
            14.3.8.1. Company Overview
            14.3.8.2. Product Portfolio
            14.3.8.3. SWOT Analysis
            14.3.8.4. Financial Overview
            14.3.8.5. Strategic Overview
        14.3.9. NIDEK Co., Ltd.
            14.3.9.1. Company Overview
            14.3.9.2. Product Portfolio
            14.3.9.3. SWOT Analysis
            14.3.9.4. Financial Overview
            14.3.9.5. Strategic Overview
        14.3.10. STAAR Surgical Company
            14.3.10.1. Company Overview
            14.3.10.2. Product Portfolio
            14.3.10.3. SWOT Analysis
            14.3.10.4. Financial Overview
            14.3.10.5. Strategic Overview
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


 
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			